NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The former OpenAI business partners are embroiled in a high-stakes dispute over the future of one of the world’s top AI companies.Read More